MENU
IONS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ionis Pharmaceuticals (IONS) Earnings Date & Reports
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
IONS is expected to report earnings to rise 76.81% to -122 cents per share on November 04
Q3'26
Est.
$-1.22
Q2'26
Beat
by $0.37
Q1'26
Beat
by $0.29
Q4'25
Missed
by $0.08
Q3'25
Beat
by $0.42
The last earnings report on July 29 showed earnings per share of -68 cents, beating the estimate of -105 cents. With 1.62M shares outstanding, the current market capitalization sits at 9.31B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of antisense drugs
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
1402
Web
https://www.ionis.com